Nomenclature for angiotensin receptors. A report of the Nomenclature Committee of the Council for High Blood Pressure Research.-Reference-Cited by-同舟云学术

Nomenclature for angiotensin receptors. A report of the Nomenclature Committee of the Council for High Blood Pressure Research.

Published:1991-05 Issue:5 Volume:17 Page:720-721
ISSN:0194-911X
Container-title:Hypertension
language:en
Short-container-title:Hypertension

Author:

Bumpus F M¹,Catt K J¹,Chiu A T¹,DeGasparo M¹,Goodfriend T¹,Husain A¹,Peach M J¹,Taylor D G¹,Timmermans P B¹

Affiliation:

1. Department of Heart and Hypertension Research, Cleveland Clinic Foundation, OH 44195.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Internal Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/01.HYP.17.5.720

Reference6 articles.

1. Chiu AT Herblin WF McCall DE Ardecky RJ Carini DJ Duncia JV Pease LJ Wong PC Wexler RR Johnson AL Timmennans PBMWM: Identification of angiotensin II recep

2. Two distinct angiotensin II receptor binding sites in rat adrenal revealed by new selective nonpeptide ligands;Chang RS;Mot Pharmacol,1990

3. Subclasses of angiotensin II binding sites and their functional significance;Dudley DT;Mol Pharmacol,1990

4. Preliminary biochemical characterization of two angiotensin II receptor subtypes

5. TiPS receptor nomenclature supplement;Watson S;Trends Pharmacol Sci,1990

Cited by 420 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alternative Renin-Angiotensin System;Hypertension;2024-05

2. Emerging opportunities to treat idiopathic pulmonary fibrosis: Design, discovery, and optimizations of small-molecule drugs targeting fibrogenic pathways;European Journal of Medicinal Chemistry;2023-11

3. Prostaglandin E₂Induces Long-Lasting Inhibition of Noradrenergic Neurons in the Locus Coeruleus and Moderates the Behavioral Response to Stressors;The Journal of Neuroscience;2023-09-21

4. Is chymase 1 a therapeutic target in cardiovascular disease?;Expert Opinion on Therapeutic Targets;2023-08-03

5. Functional crosstalk between angiotensin receptors (types 1 and 2) and relaxin family peptide receptor 1 (RXFP1): Implications for the therapeutic targeting of fibrosis;British Journal of Pharmacology;2023-01-17